NCT02092051 - CGM Treatment in Patients With Type 1 Diabetes Treated With Insulin Injections | Biotech Hunter

Enrollment

161

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions

Diabetes Mellitus, Type 1

Interventions

DEVICE

Continuous glucose monitoring with DexCom G4 platina

Trial Locations (15)

25187

Helsingborg Hospital, Helsingborg

29185

Centralhospital Kristianstad, Kristianstad

42422

Angered Hospital, Angered

43480

Halland's Hospital Kungsbacka, Kungsbacka

44183

Alingsås Hospital, Alingsås

45180

Uddevalla Hospital, Uddevalla

70185

University Hospital Örebro, Örebro

75185

Academic Hospital Uppsala, Uppsala

262 81

Ängelholm Hospital, Ängelholm

871 82

Öbackakliniken, Härnösand

205 02

Malmö University Hospital, Malmo

591 85

Motala Hospital, Motala

603 82

Vrinnevisjukhuset, Norrköping

118 81

Södersjukhuset, Stockholm

231 85

Trelleborg Hospital, Trelleborg

All Listed Sponsors

collaborator

DexCom, Inc.

INDUSTRY

lead

Vastra Gotaland Region

OTHER_GOV